Dr. Ondeck is a clinician scientist in the glaucoma department with an interest in extended drug delivery for ophthalmic applications. Glaucoma is one of the most prevalent ophthalmologic disorders and is still a common cause of vision loss. Topical medications and surgeries are currently available to manage glaucoma; however, complications can arise from surgery, and there can be issues with compliance and side effects from medications that can make these treatments less effective.
Dr. Ondeck is interested in developing an extended release delivery system of glaucoma medications. She has a background in materials science and biomedical engineering, nanotechnology and polymer chemistry and wishes to combine her background with her training in glaucoma to develop drug delivery techniques and/or devices that could eliminate the need for daily eye drops. Her goal is to develop a biocompatible device that can be impregnated with intraocular lowering medications, with the intention that it would be more effective than topical medications in the treatment of glaucoma.
Download her CV for more information.
2008: BS, with University and College Honors, Materials Science Engineering and Biomedical Engineering, Carnegie Mellon University
2009: MPhil, Chemistry, University of Cambridge – Churchill College
2013: MD, Washington University at St. Louis School of Medicine
2014: Internship, Preliminary Medicine, North Shore Medical Center, Salem, MA
2017: Residency, Ophthalmology, University of California, San Diego
2018: Fellowship, Glaucoma, Duke University
Cambridge Overseas Trust Scholar
Starr E. Shulman MPA Fellow
AAO Advocacy Ambassador
Andrew Carnegie Society Scholar
Phi Kappa Phi Honor Society, National Graduate Fellowship – Slater Fellow